Bioxodes is a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of therapeutics for patients with thrombo-inflammatory diseases. We leverage our deep understanding of the thrombotic and inflammatory processes to design novel product candidates with an aim to address unmet medical needs.
Location: Belgium, Luxembourg, Marche-en-Famenne
Employees: 11-50
Total raised: $16.665718M
Founded date: 2013
Investors 1
Funding Rounds 2
| Date | Series | Amount | Investors |
| 21.11.2023 | Series A | $13.137755... | - |
| 26.11.2013 | Seed | $3.527963M | - |
Mentions in press and media 4
| Date | Title | Description | Source |
| 21.11.2023 | Bioxodes Raises €12M in Series A Funding Round | Bioxodes, a Gosselies, Belgium-based biopharmaceutical company which specializes in the development ... | finsmes.co... |
| 19.09.2023 | Can Novel Biotech Therapeutics Revolutionize Global Health C... | Key Takeaways: Bioxodes is a startup company in the biotechnology and health care industry, working ... | eustartup.... |
| 26.11.2013 | Bioxodes Completes €2.6M Seed Funding | Bioxodes SA, a Marche-en-Famenne, Belgium-based developer of products derived from natural sources, ... | finsmes.co... |
| 26.11.2013 | Bioxodes Raises EUR 2.6M in Seed Funding | MARCHE-EN-FAMENNE, BELGIUM, Bioxodes SA, a company developing products derived from natural source... | vcnewsdail... |